aldesta 75mg injekční roztok v předplněné injekční stříkačce - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

vafseo vadadustat 150 mg tablet blister pack

adjutor healthcare pty ltd - vadadustat, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; hypromellose; silicon dioxide; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

vafseo vadadustat 300 mg tablet blister pack

adjutor healthcare pty ltd - vadadustat, quantity: 300 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; microcrystalline cellulose; hypromellose; silicon dioxide; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

vafseo vadadustat 450 mg tablet blister pack

adjutor healthcare pty ltd - vadadustat, quantity: 450 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; hypromellose; magnesium stearate; silicon dioxide; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - vafseo is indicated for the treatment of anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

European Union - English - EMA (European Medicines Agency)

vafseo

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemic preparations - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.

European Union - English - EMA (European Medicines Agency)

evrenzo

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianemic preparations - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).